Hallmark Services, Inc Revenu Y/Y
Quel est le Revenu Y/Y de Hallmark Services, Inc?
Le Revenu Y/Y de Hallmark Financial Services, Inc est -43.85%
Quelle est la définition de Revenu Y/Y?
La croissance annuelle des revenus des trois dernières années correspond à la croissance moyenne des revenus d’une année sur l’autre au cours des trois dernières années.
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
Revenu Y/Y des entreprises dans Finance secteur sur NASDAQ par rapport à Hallmark Services, Inc
Que fait Hallmark Services, Inc?
hallmark financial services, inc. is an insurance holding company which, through its subsidiaries, engages in the sale of property/casualty insurance products to businesses and individuals. hallmark's business involves marketing, distributing, underwriting and servicing commercial and personal lines of property/casualty insurance products, as well as providing other insurance related services. hallmark is headquartered in fort worth, texas and its common stock is listed on nasdaq under the symbol "hall."
Entreprises avec revenu y/y similaire à Hallmark Services, Inc
- Sealand Capital Galaxy a Revenu Y/Y de -44.25%
- Graphite India a Revenu Y/Y de -44.13%
- Truist a Revenu Y/Y de -44.11%
- WhiteHawk a Revenu Y/Y de -44.03%
- Gujarat Fluorochemicals a Revenu Y/Y de -43.96%
- Medifast Inc a Revenu Y/Y de -43.90%
- Hallmark Services, Inc a Revenu Y/Y de -43.85%
- Cheniere a Revenu Y/Y de -43.83%
- Mobilicom a Revenu Y/Y de -43.79%
- Telesis Bio Inc a Revenu Y/Y de -43.65%
- Clene Nanomedicine a Revenu Y/Y de -43.62%
- Shandong Molong Petroleum Machinery a Revenu Y/Y de -43.62%
- Protalix BioTherapeutics a Revenu Y/Y de -43.59%